Menu
20/05/2022
Health Minister Welcomes Innovative Antiviral Treatment Study
Health Minister, Robin Swann, has welcomed the successful roll-out of an innovative COVID-19 antiviral treatment study as he marks International Clinical Trials Day.
The Health Minister visited the Northern Ireland Clinical Research Network (NICRN) where the Primary Care team have supported over 1,000 local patients to participate in the UK-wide PANORAMIC study on an antiviral treatment.
Speaking after the visit, the Minister said: "There is no doubt that one of the legacies of COVID-19 will be the pace at which new treatments and vaccines were made available. Of course these new developments would not have been possible without the researchers behind studies such as this, and the people who stepped forward to participate.
"I want to commend the team at NICRN for the work they have undertaken as part of the PANORAMIC study. People from Northern Ireland willingly volunteered for the study which will inevitably help us understand how best to use antiviral treatments and who will benefit most from them."
Patients at higher risk from COVID-19 infection were able to participate in the study investigating the oral antiviral molnupiravir, which launched in December in 2021. Since then more than 25,000 people from across the UK signed up to the University of Oxford study which was set up to rapidly evaluate if antiviral treatments help people at higher risk of COVID-19 to recover sooner and prevent the need for hospital admission. Recruitment for the antiviral molnupiravir arm of the study closed at the end of April 2022 and it is anticipated that interim results may be available this summer.
Chief Pharmaceutical Officer Cathy Harrison said: "I would like to take this opportunity on International Clinical Trials Day to thank the PANORAMIC team for their outstanding work which will help inform how these medicines may be deployed more widely in the future and ultimately help us to provide care for the most at risk from COVID-19."
Professor Nigel Hart, co-lead of the NICRN Primary Care group and Lead Investigator for PANORAMIC in NI, added: "International Clinical Trials day reminds us of the importance of nurturing a trusted collaboration between society and the research community to produce the evidence on which the best treatment choices can be made."
The University of Oxford is now investigating an additional antiviral, Paxlovid, within the PANORAMIC study. Recruitment to the Paxlovid arm initially began in England from April however the Department of Health and Social Care is working with the PANORAMIC study team to develop plans for how Paxlovid could potentially become available through the study in Northern Ireland in due course.
The Health Minister visited the Northern Ireland Clinical Research Network (NICRN) where the Primary Care team have supported over 1,000 local patients to participate in the UK-wide PANORAMIC study on an antiviral treatment.
Speaking after the visit, the Minister said: "There is no doubt that one of the legacies of COVID-19 will be the pace at which new treatments and vaccines were made available. Of course these new developments would not have been possible without the researchers behind studies such as this, and the people who stepped forward to participate.
"I want to commend the team at NICRN for the work they have undertaken as part of the PANORAMIC study. People from Northern Ireland willingly volunteered for the study which will inevitably help us understand how best to use antiviral treatments and who will benefit most from them."
Patients at higher risk from COVID-19 infection were able to participate in the study investigating the oral antiviral molnupiravir, which launched in December in 2021. Since then more than 25,000 people from across the UK signed up to the University of Oxford study which was set up to rapidly evaluate if antiviral treatments help people at higher risk of COVID-19 to recover sooner and prevent the need for hospital admission. Recruitment for the antiviral molnupiravir arm of the study closed at the end of April 2022 and it is anticipated that interim results may be available this summer.
Chief Pharmaceutical Officer Cathy Harrison said: "I would like to take this opportunity on International Clinical Trials Day to thank the PANORAMIC team for their outstanding work which will help inform how these medicines may be deployed more widely in the future and ultimately help us to provide care for the most at risk from COVID-19."
Professor Nigel Hart, co-lead of the NICRN Primary Care group and Lead Investigator for PANORAMIC in NI, added: "International Clinical Trials day reminds us of the importance of nurturing a trusted collaboration between society and the research community to produce the evidence on which the best treatment choices can be made."
The University of Oxford is now investigating an additional antiviral, Paxlovid, within the PANORAMIC study. Recruitment to the Paxlovid arm initially began in England from April however the Department of Health and Social Care is working with the PANORAMIC study team to develop plans for how Paxlovid could potentially become available through the study in Northern Ireland in due course.
Related Northern Ireland News Stories
Click here for the latest headlines.
17 January 2023
Call For Participants For New Antiviral Treatment Study
The Department of Health has appealed for participants to take part in the latest phase of a UK wide study to investigate antiviral treatments for COVID-19.
Call For Participants For New Antiviral Treatment Study
The Department of Health has appealed for participants to take part in the latest phase of a UK wide study to investigate antiviral treatments for COVID-19.
25 March 2022
Ground-Breaking Clinical Trial 'Exceeds Expectations" In NI
A ground-breaking Covid-19 clinical trial has "exceeded expectations" in Northern Ireland, Health Minister Robin Swann has said as he thanked NI researchers involved in the PANORAMIC study.
Ground-Breaking Clinical Trial 'Exceeds Expectations" In NI
A ground-breaking Covid-19 clinical trial has "exceeded expectations" in Northern Ireland, Health Minister Robin Swann has said as he thanked NI researchers involved in the PANORAMIC study.
25 January 2022
Call For Participants In World Leading Covid-19 Antiviral Drug Study
The Health Minister, Robin Swann, has called for people in Northern Ireland to take part in a world leading study on life-saving COVID-19 antiviral drugs. The PANORAMIC trial, run by the University of Oxford, is open to the over-50s, as well as adults with an underlying health condition, if they test positive for COVID-19.
Call For Participants In World Leading Covid-19 Antiviral Drug Study
The Health Minister, Robin Swann, has called for people in Northern Ireland to take part in a world leading study on life-saving COVID-19 antiviral drugs. The PANORAMIC trial, run by the University of Oxford, is open to the over-50s, as well as adults with an underlying health condition, if they test positive for COVID-19.
15 November 2024
Winter Vaccines: Get Boosted To Protect Yourself
The Public Health Agency (PHA) is urging eligible individuals in Northern Ireland to get their annual flu and COVID-19 vaccines as soon as possible. The agency highlights the significant benefits of vaccination in reducing severe illness and death, especially for those at high risk.
Winter Vaccines: Get Boosted To Protect Yourself
The Public Health Agency (PHA) is urging eligible individuals in Northern Ireland to get their annual flu and COVID-19 vaccines as soon as possible. The agency highlights the significant benefits of vaccination in reducing severe illness and death, especially for those at high risk.
09 December 2021
Range Of New Treatment Options For Covid-19 Patients Announced
The UK government has announced a range of new treatment options for COVID-19 patients who are at the highest risk from the effects of the virus. To date, most COVID-19 treatments have focused on hospitalised patients.
Range Of New Treatment Options For Covid-19 Patients Announced
The UK government has announced a range of new treatment options for COVID-19 patients who are at the highest risk from the effects of the virus. To date, most COVID-19 treatments have focused on hospitalised patients.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
